Hosted on MSN10mon
Tandem’s insulin pump app glitch triggers FDA Class I recallTandem also advised its users to carry backup supplies for insulin delivery in case the pump fails. The US diabetes market is expected to grow at a compound annual growth rate (CAGR) of 5.35% and ...
Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...
system can pull data from glucose monitors and integrate with Tandem’s insulin pumps, automatically calculating how much basal insulin patients should receive. The expanded indication increases ...
The "correction" as referred to by the FDA on Wednesday, rather than a product removal, relates to the t:connect Mobile App iOS v2.7. It was confirmed by Tandem ... insulin pumps to carry backup ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...
Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...
“It is a natural evolution of our mission to bring the same AID technology that helped to make Tandem the #1 recommended insulin pump brand by both healthcare providers and people living with ...
in conjunction with Tandem’s t:slim X2 and Mobi insulin pumps, was already approved for people with type 1 diabetes aged 2 years or older. The new indication is for people with T2D aged 18 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results